I agree that overall the market is more accurate than one individual investor. But in order for that to be true, the market overwhelmingly would have to be informed about the Company, it’s products and it’s potential. We are no where close to information about CytoDyn being saturated within the current market. It also doesn’t take into consideration that we will soon be in a larger and more accessible market. The theory that demand and supply are at the point of intersection might be true, but in my observation it is temporary as there are new developments and up listing to a more accessible market is right around the corner.